This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Kanako Masuda: Innovator in Cell Culture Technology
Introduction
Kanako Masuda is a prominent inventor based in Kumamoto-ken, Japan. She has made significant contributions to the field of cell culture technology, particularly in the development of a novel cell line that enhances vaccine production processes. Her work is characterized by a focus on safety, cost-effectiveness, and efficiency.
Latest Patents
Masuda holds a patent for a "Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell." This innovative MDCK-derived cell line, designated as B-702, can be cultivated without fetal calf serum and in suspension culture. This advancement allows for large-scale tank culture production and eliminates the need for carriers in suspension culture. The process she developed for producing viruses for vaccines using this cell line is both low-cost and highly safe.
Career Highlights
Kanako Masuda is affiliated with the Juridical Foundation the Chemo-Sero-Therapeutic Research Institute, where she continues to advance her research. Her dedication to improving vaccine production methods has positioned her as a key figure in her field.
Collaborations
Masuda has collaborated with notable colleagues, including Keiichi Makizumi and Yoichiro Kino. Their combined expertise has contributed to the success of her innovative projects.
Conclusion
Kanako Masuda's work in cell culture technology represents a significant advancement in vaccine production. Her innovative approaches and dedication to research continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile